Mirion Technologies Inc. Class A Common Stock Earnings Recaps
Mirion’s shares rose 8.7% after earnings, with the market responding to a 62% increase in organic orders and management’s expectation of mid- to high-teens organic revenue growth in Q4. The upside is tempered by management’s admission that its 2028 margin target was too aggressive, citing slower medical growth, delayed Paragon margin expansion, and increased investment priorities.
Key takeaways
- Q3 orders rose 62% year over year excluding M&A to $340 million; total orders, including Paragon and Certrec, increased 85% to $386 million.
- Nuclear power orders more than doubled excluding M&A, while trailing 12-month orders grew 37% excluding M&A; management said the installed base was the largest year-over-year contributor.
- Organic revenue grew 6.5% in Q3. Management expects mid- to high-teens organic growth in Q4 and revised full-year 2026 guidance, though the transcript excerpt does not provide the full guidance figures.
- Management said its previously announced 2028 margin target was too aggressive, pointing to tempered medical organic growth and Paragon margin expansion running behind initial expectations. It plans to prioritize AI and cybersecurity investment while targeting annual margin expansion.
- Mirion expects net leverage to improve to approximately 2.6x by year-end, supported by expected Q4 earnings growth and cash generation.
Mirion shares gained 5.7% following Q1, as accelerating Nuclear Power orders and a surge in backlog materially outpaced market expectations. Recent acquisitions, Paragon and Certrec, contributed to substantial order and revenue growth, with integration delivering above-plan results.
Key takeaways
- Company-wide orders rose 19% year-over-year to $241 million, or 42% to $288 million including M&A, with growth across both segments.
- Backlog expanded to $1.1 billion, increasing 19% excluding M&A, or 38% including deals.
- Paragon contributed $43 million in orders and delivered 45% revenue growth in Q1, with improving operating leverage and margins.
- Large opportunity orders totaled $50 million in Q1, with an additional $35 million secured in April from SMR-related projects, supporting visibility into future performance.
- Integration of Paragon and Certrec is yielding enhanced customer access and expanding Mirion’s addressable market at a time of sharply rising Nuclear Power capital spending.
Mirion Technologies reported a strong third quarter in 2025 with revenue expanding nearly 8% year-over-year, driven by robust demand in the nuclear power sector, positioning the company well for future growth.
Key takeaways
- Third quarter revenue reached $223 million, representing a nearly 8% increase, with organic growth of 4.7%.
- Adjusted EBITDA rose 14.7% to $52.4 million, reflecting contributions from both the Nuclear and Safety and Medical segments.
- The nuclear power segment saw 9% organic revenue growth, with adjusted orders in the sector increasing 21%.
- Adjusted free cash flow for the quarter was $18 million, elevating year-to-date total to $53 million, prompting an increase in the low end of cash flow guidance to $100-$115 million.
- Mirion is on track to close the acquisition of Paragon Energy Solutions by year-end, further enhancing its nuclear power portfolio.